A fortnight after offering news that it will be using Apple’s ReasearchKit to conduct arthritis research, drug giant GlaxoSmithKline has announced that it will be teaming with Verily, the Alphabet-owned LLC formerly known as Google Life Sciences, to create Galvani Bioelectronics. The jointly owned venture (55-percent GSK, 45-percent Verily) will work to explore bioelectronic medicine,… Read More...